1. Home
  2. IMNM vs VREX Comparison

IMNM vs VREX Comparison

Compare IMNM & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • VREX
  • Stock Information
  • Founded
  • IMNM 2006
  • VREX 2016
  • Country
  • IMNM United States
  • VREX United States
  • Employees
  • IMNM N/A
  • VREX N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • VREX Industrial Machinery/Components
  • Sector
  • IMNM Health Care
  • VREX Technology
  • Exchange
  • IMNM Nasdaq
  • VREX Nasdaq
  • Market Cap
  • IMNM 585.5M
  • VREX 582.3M
  • IPO Year
  • IMNM 2020
  • VREX N/A
  • Fundamental
  • Price
  • IMNM $9.99
  • VREX $13.52
  • Analyst Decision
  • IMNM Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • IMNM 5
  • VREX 1
  • Target Price
  • IMNM $28.60
  • VREX $21.00
  • AVG Volume (30 Days)
  • IMNM 881.8K
  • VREX 475.8K
  • Earning Date
  • IMNM 11-13-2024
  • VREX 02-04-2025
  • Dividend Yield
  • IMNM N/A
  • VREX N/A
  • EPS Growth
  • IMNM N/A
  • VREX N/A
  • EPS
  • IMNM N/A
  • VREX N/A
  • Revenue
  • IMNM $10,129,000.00
  • VREX $811,000,000.00
  • Revenue This Year
  • IMNM N/A
  • VREX $3.50
  • Revenue Next Year
  • IMNM N/A
  • VREX $3.37
  • P/E Ratio
  • IMNM N/A
  • VREX N/A
  • Revenue Growth
  • IMNM N/A
  • VREX N/A
  • 52 Week Low
  • IMNM $8.97
  • VREX $10.19
  • 52 Week High
  • IMNM $30.96
  • VREX $20.27
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 40.28
  • VREX 36.98
  • Support Level
  • IMNM $9.24
  • VREX $13.47
  • Resistance Level
  • IMNM $11.06
  • VREX $13.99
  • Average True Range (ATR)
  • IMNM 0.74
  • VREX 0.41
  • MACD
  • IMNM -0.06
  • VREX -0.08
  • Stochastic Oscillator
  • IMNM 31.78
  • VREX 18.69

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.

Share on Social Networks: